Awesome post. This reminds me of an article from 2007 I read on the weekend. It's 50 odd pages but well worth the read if you have the time. Very helpful if anyone wants more information on:
- method of action and the science behind why pentosan can do what it does - the potential pipeline of indications, in case you were worried the company is a one trick pony - ie. OA or bust - context behind why PPS has yet to be commercialised beyond elmiron and animal use - PAR's links to Biopharm/Arthropharm (the maker of Cartrophen Vet) through Prof Peter Ghosh
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)